We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVLR
901
DELISTED
Avalara, Inc.
AVLR
| $769K | ﹤0.01% |
10,500
+7,400
| +239% | +$538K |
|
|
FLG
902
Flagstar Bank National Association
FLG
$5.22B
| $767K | ﹤0.01% |
21,267
-1,633
| -7% | -$60.3K |
|
903
Dr. Reddy's Laboratories
RDY
$9.73B
| $765K | ﹤0.01% |
94,275
| – | – |
|
904
Campbell Soup
CPB
$6.38B
| $746K | ﹤0.01% |
15,103
-97
| -0.6% | -$4.6K |
|
905
TripAdvisor
TRIP
$1.05B
| $732K | ﹤0.01% |
24,100
| – | – |
|
906
Western Alliance Bancorporation
WAL
$8.49B
| $730K | ﹤0.01% |
+12,800
| New | +$654K |
|
|
AIV
907
Aimco
AIV
$327M
| $726K | ﹤0.01% |
105,576
-1,508,867
| -93% | -$10.7M |
|
908
iShares Russell 2000 ETF
IWM
$76.5B
| $724K | ﹤0.01% |
4,372
-753
| -15% | -$119K |
|
|
SRT
909
DELISTED
Startek Inc.
SRT
| $724K | ﹤0.01% |
90,672
| – | – |
|
910
WhiteHorse Finance
WHF
$157M
| $723K | ﹤0.01% |
+52,800
| New | +$738K |
|
911
Dollar Tree
DLTR
$21.1B
| $718K | ﹤0.01% |
7,636
+317
| +4% | +$33.3K |
|
|
ANAT
912
DELISTED
American National Group, Inc. Common Stock
ANAT
| $718K | ﹤0.01% |
6,100
-1,800
| -23% | -$213K |
|
913
Hurco Companies Inc
HURC
$147M
| $704K | ﹤0.01% |
18,363
| – | – |
|
|
PBCT
914
DELISTED
People's United Financial Inc
PBCT
| $703K | ﹤0.01% |
41,600
| – | – |
|
915
Upbound Group
UPBD
$1.04B
| $701K | ﹤0.01% |
24,300
-13,500
| -36% | -$353K |
|
|
UBA
916
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $695K | ﹤0.01% |
27,970
| – | – |
|
917
Manitowoc
MTW
$753M
| $684K | ﹤0.01% |
+39,103
| New | +$570K |
|
|
CNCE
918
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $683K | ﹤0.01% |
74,083
| – | – |
|
919
Crown Holdings
CCK
$12.2B
| $682K | ﹤0.01% |
9,400
| – | – |
|
920
Xcel Energy
XEL
$45.4B
| $680K | ﹤0.01% |
10,711
-12,071
| -53% | -$755K |
|
|
FPRX
921
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $672K | ﹤0.01% |
146,371
-171,905
| -54% | -$681K |
|
922
Qiagen
QGEN
$8.86B
| $665K | ﹤0.01% |
18,554
-214,110
| -92% | -$7.96M |
|
|
JNPR
923
DELISTED
Juniper Networks
JNPR
| $663K | ﹤0.01% |
26,925
-30,700
| -53% | -$755K |
|
924
Louisiana-Pacific
LPX
$4.57B
| $662K | ﹤0.01% |
22,300
| – | – |
|
925
NetApp
NTAP
$37.6B
| $659K | ﹤0.01% |
10,569
+5,728
| +118% | +$334K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.